.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

ZOMIG Drug Profile

« Back to Dashboard
Zomig is a drug marketed by Astrazeneca and IPR and is included in three NDAs. It is available from five suppliers. There are two patents protecting this drug and one Paragraph IV challenge.

The generic ingredient in ZOMIG is zolmitriptan. There are twenty drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the zolmitriptan profile page.

Summary for Tradename: ZOMIG

Patents:2
Applicants:2
NDAs:3
Suppliers / Packagers: see list5

Clinical Trials for: ZOMIG

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Astrazeneca
ZOMIG
zolmitriptan
SPRAY;NASAL021450-003Sep 16, 2013RXNo7,220,767*PED<disabled>Y<disabled>
Ipr
ZOMIG
zolmitriptan
TABLET;ORAL020768-001Nov 25, 1997RXNo<disabled><disabled>
Astrazeneca
ZOMIG
zolmitriptan
SPRAY;NASAL021450-004Sep 30, 2003RXYes7,220,767*PED<disabled>Y<disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: ZOMIG

These historical archives are available as an add-on to one-year subscriptions.
See the Signup Form for more information.

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Astrazeneca
ZOMIG
zolmitriptan
SPRAY;NASAL021450-004Sep 30, 20035,466,699*PED<disabled>
Ipr
ZOMIG
zolmitriptan
TABLET;ORAL020768-001Nov 25, 19975,863,935*PED<disabled>
Ipr
ZOMIG
zolmitriptan
TABLET;ORAL020768-002Nov 25, 19975,863,935*PED<disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: ZOMIG

Drugname Dosage Strength RLD Submissiondate
zolmitriptanNasal Spray5 mg/sprayZomig11/14/2013
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

`abc